Mediation analysis of CRP on the association of physical activity with FEV1 and FVC: the ECRHS study.
E. Fuertes (Barcelona, Spain), A. Carsin (Barcelona, Spain), V. Larsen (Baltimore, MD 21205, United States of America), S. Guerra (Tucson, Arizona, United States of America), I. Pin (Grenoble, France), B. Leynaert (Paris, France), S. Accordini (Verona, Italy), J. Martinez-Moratalla (Albacete, Spain), J. Anto (Barcelona, Spain), I. Urrutia (Galdakao, Spain), A. Le Gouellec (Grenoble, France), J. Heinrich (Munich, Germany), T. Gislason (Reykjavik, Iceland), R. JõGi (Tartu, Estonia), C. Janson (Uppsala, Sweden), D. Jarvis (London, United Kingdom), J. Garcia-Aymerich (Barcelona, Spain)
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Fuertes (Barcelona, Spain), A. Carsin (Barcelona, Spain), V. Larsen (Baltimore, MD 21205, United States of America), S. Guerra (Tucson, Arizona, United States of America), I. Pin (Grenoble, France), B. Leynaert (Paris, France), S. Accordini (Verona, Italy), J. Martinez-Moratalla (Albacete, Spain), J. Anto (Barcelona, Spain), I. Urrutia (Galdakao, Spain), A. Le Gouellec (Grenoble, France), J. Heinrich (Munich, Germany), T. Gislason (Reykjavik, Iceland), R. JõGi (Tartu, Estonia), C. Janson (Uppsala, Sweden), D. Jarvis (London, United Kingdom), J. Garcia-Aymerich (Barcelona, Spain). Mediation analysis of CRP on the association of physical activity with FEV1 and FVC: the ECRHS study.. 4483
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Determinants of the relationship between changes in FEV1 and SGRQ: analysis of the TORCH data Source: Annual Congress 2008 - COPD Year: 2008
Natural decline in FEV1 and FVC: Self versus reference equations Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015
The association of FVC with quality of life – The PneumoLaus|PsyCoLaus study Source: Virtual Congress 2020 – Management of chronic lung conditions Year: 2020
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1 Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016
The relationship between long-term correlations (self-similarity) in PEF and FEV1 in COPD Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Longitudinal modeling of prebronchodilator FEV1 response to benralizumab for patients with severe asthma Source: International Congress 2017 – Asthma management Year: 2017
Assessment of the relationship between FEF25-75/FVC ratio and reversibility in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
Comparison of prebronchodilator FEV1/FEV6 of handheld spirometry with postbronchodilator FEV1/FVC of spirometry in Korea: a pilot study Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Comparative study of FEV1 /FVC and FEV1 /FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Correlation of various parameters with FEV1 in the assessment of asthma severity Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001
FEV1/FVC agreement study between two different seasons Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag study Source: Eur Respir J 2001; 18: 770-779 Year: 2001
Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
Objective moderate-to-vigorous physical activity in 1064 patients with COPD after stratification for gender, FEV1 and BMI Source: Annual Congress 2013 –The best abstracts in physical inactivity and exercise training in COPD Year: 2013
Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2011 - COPD diagnosis Year: 2011